Compare KRYS & VLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRYS | VLY |
|---|---|---|
| Founded | 2015 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.6B |
| IPO Year | 2017 | N/A |
| Metric | KRYS | VLY |
|---|---|---|
| Price | $246.66 | $12.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $226.56 | $13.14 |
| AVG Volume (30 Days) | 289.5K | ★ 5.9M |
| Earning Date | 02-18-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 3.64% |
| EPS Growth | ★ 275.72 | 40.78 |
| EPS | ★ 6.66 | 0.88 |
| Revenue | $373,164,000.00 | ★ $1,704,193,000.00 |
| Revenue This Year | $36.14 | $33.72 |
| Revenue Next Year | $41.80 | $10.15 |
| P/E Ratio | $37.43 | ★ $13.74 |
| Revenue Growth | ★ 54.51 | 8.06 |
| 52 Week Low | $122.80 | $7.48 |
| 52 Week High | $265.92 | $12.18 |
| Indicator | KRYS | VLY |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 64.47 |
| Support Level | $235.61 | $11.54 |
| Resistance Level | $257.95 | $12.01 |
| Average True Range (ATR) | 7.62 | 0.21 |
| MACD | -1.55 | -0.02 |
| Stochastic Oscillator | 57.06 | 82.68 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.